论文部分内容阅读
本文总结了心血管药物近年来临床研究的新进展,包括肾上腺素β受体阻滞剂、钙通道阻滞剂、血管紧张素转化酶抑制剂、抗心力衰竭药、抗心律失常药、抗心肌缺血药、抗高血压药、降血脂药、抗血小板药和抗血栓药。提示心血管药物在基础理论指导下,新药品种层出不穷,使心血管疾病的药物治疗发生了重大改观,促进了临床医学的发展。本文有助于医药工作者了解心血管药物的全貌,特别可提供制药厂在开发和研究心血管新药时作参考。
This article summarizes the recent advances in the clinical research of cardiovascular drugs, including adrenergic beta-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, anti-heart failure drugs, antiarrhythmic drugs, anti-cardiac Ischemic drugs, antihypertensives, hypolipidemic drugs, antiplatelet drugs and antithrombotic drugs. Prompted cardiovascular drugs Under the guidance of basic theory, an endless stream of new drug varieties, the cardiovascular disease drug treatment has undergone major changes, and promote the development of clinical medicine. This article helps medical practitioners understand the whole picture of cardiovascular drugs and, in particular, provides reference for pharmaceutical companies in the development and research of new cardiovascular drugs.